Evaluation of a Structurally Suitable Neck Exoskeleton in Patients With Amyotrophic Lateral Sclerosis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorUniversity of Utah

About this trial

The investigators will evaluate a new powered neck exoskeleton in patients with amyotrophic lateral sclerosis (ALS) to understand whether this device allows adequate head range of motion and achieves satisfaction from users. In this small cross-sectional device feasibility study, participants will be enrolled from the ALS clinic at the University of Utah Hospital. After obtaining written consent, participants will perform tasks using the neck exoskeleton. Tasks include computerized tracking tasks and simulated activities of daily living. Breaks will be added between tasks to avoid fatigue. Head-neck kinematics will be recorded, and range of motion will be computed. Participants will also report their satisfaction of the device.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

ALS diagnosis and neck weakness

Disqualifiers

Any cognitive deficits or visual impairments that would prevent from safely using the device and completing the tasks.

Trial design

Design model

Single group

Treatments tested in this trial

  • powered neck exoskeleton

    Device

    Subjects will use the powered neck exoskeleton to control their head-neck motion to complete tasks involving head-neck motions. The neck exoskeleton will be worn and controlled by the users to assist them during tasks.

Treatment groups

10 Participants
are divided into 1 treatment group
Group A: powered neck exoskeletonExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

range of motion

head range of motion (relative to torso) in three anatomical planes

Time frame
during the intervention (using the exoskeleton to complete tasks) approximately 1 hour

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.